|
|
||||||||
RECEPTORS AND SIGNAL TRANSDUCTION
1Section of Neurology, St. Christopher's Hospital for Children, Drexel University College of Medicine, Philadelphia, Pennsylvania; 2Department of Neurology, University of Pennsylvania, Philadelphia, Pennsylvania; and 3Department of Physiology and Biophysics, State University of New York, Stony Brook, New York
Submitted 9 January 2007 ; accepted in final form 29 June 2007
| ABSTRACT |
|---|
|
|
|---|
gap junctions; hearing; fluorescence resonance energy transfer; fluorescence recovery after photobleaching; immunoprecipitation; dye transfer; electrophysiology
5,000 Da (59) and are thought to have diverse functions, including the propagation of electrical signals, metabolic cooperation, spatial buffering of ions, growth control, and cellular differentiation (8). They are formed by two apposed hemichannels (or connexons); a complete channel is formed when one hemichannel docks with a compatible hemichannel on an apposed cell membrane. Each hemichannel is comprised of six compatible connexin molecules, a large family of highly conserved proteins, usually named according to their predicted molecular mass (64). Individual hemichannels can be composed of one (homomeric) or more than one (heteromeric) type of connexin. Similarly, channels can be composed of hemichannels containing the same (homotypic) or different (heterotypic) connexins (34, 63). Any two compatible connexins can theoretically form 196 different channels (7). Mutations in GJB2 and GJB6, the genes that encode the human gap junction proteins connexin26 (Cx26) and connexin30 (Cx30), cause hearing loss (43). The Connexin-Deafness homepage is http://davinci.crg.es/deafness. Recessive mutations of GJB2/Cx26 are the most common cause of nonsyndromic hearing loss, accounting for 50% of such patients. Dominant mutations in GJB2/Cx26 (either in isolation or as part of a syndrome that includes a variety of skin diseases) and GJB6/Cx30 also cause hearing loss. Cx26 and Cx30 are coexpressed in the affected tissues, the cochlea, and the skin (2, 22, 33, 35, 44), so that altered functions of these proteins in the cells that express them likely account for the disease manifestations (cell autonomous effects).
Cx26 and Cx30 have broadly overlapping (but not identical) distributions and a similar profile of developmental expression (2, 23, 28, 49, 71) in rodent cochlea. It has been suggested that hybrid Cx26 and Cx30 channels may be required for normal hearing, as ablation of Cx30 or Cx26 result in hearing loss, despite continuing expression of Cx26 or Cx30 (13, 50). Cx26 and Cx30 have been coimmunoprecipitated from mouse cochlear homogenates (2, 22, 49) and from transfected cells that coexpress mouse (49) or human (16) Cx26-enhanced green fluorescent protein (EGFP) and Cx30-EGFP. Whether human Cx26 and Cx30 without epitope tags can form hybrid channels has not been demonstrated, which is a potentially important question, as species specificity of channel properties have been reported and epitope-tagged connexins may potentially affect the biophysical properties of the channels (4, 5, 9, 25, 48). To investigate this issue, we expressed human Cx26 and Cx30 individually or together in HeLa cells. Our results indicate that human Cx26 and Cx30 form functional heteromeric and heterotypic channels, whose biophysical properties and permeabilities are different from their homotypic counterparts.
| MATERIALS AND METHODS |
|---|
|
|
|---|
-competent cells. A large-scale plasmid preparation was made from a single colony (Qiagen) and sequenced at the Cell Center at the University of Pennsylvania. The correct sequences were confirmed by comparison with published GJB2/Cx26 (GenBank NM004004.3) or GJB6/Cx30 sequences. Sequence of our Cx30 clone (GenBank accession no. AY297110) showed two nucleotide differences from the published sequence (GenBank accession nos. NM006783 and AJ005585). The first change (A to C at base 108) did not alter the deduced amino acid sequence, and the second change (C to G at base 372) was predicted to result in H124Q amino acid change. We found a perfect match of our cDNA sequence with the sequence of the Human Genome Project (NT_024524
[GenBank]
.13 and NT_086801.1), the NEDO human cDNA sequencing project (GenBank accession no. AK075242), and the sequence of another human clone (BC038934
[GenBank]
). To generate connexin-ECFP or connexin-enhanced yellow fluorescent protein (EYFP) constructs, cDNAs of human Cx26, Cx30, or Cx43 were amplified by PCR using oligonucleotide primers designed to include the open reading frame, delete the stop codon, and incorporate a 5' EcoRI site and a 3' BamHI site, using Pfu Turbo polymerase. The PCR products were cloned into the EcoRI and the BamHI restriction sites of vector pECFPN1 or pEYFPN1 (Clontech). The resulting constructs included the cDNA sequences of the autofluorescent reporter proteins ECFP or cyan-yellow fluorescent protein (CYFP) fused in-frame to the COOH terminus of the open reading frame of specific connexin with a seven-amino acid linker. A large-scale plasmid preparation was made from a single colony, and all constructs were verified by automated DNA sequence as described above.
Generating cell lines expressing Cx26, Cx30, or Cx30 and Cx26.
Communication-incompetent HeLa cells (19) were grown in six-well plates, and transfection was carried out using Lipofectamine 2000 (Invitrogen) as described (66). Two days after transfection, HeLa cells were selected by adding 1 µg/ml puromycin (Sigma-Aldrich, St. Louis, MO) to the medium over 3 wk. The cells were trypsinized and plated at low density, and single colonies were picked and expanded. Cloned cells stably expressing Cx26 or Cx30 were obtaining by screening at least 30 different clones by immunostaining; of these,
8 showed stable expressions for at least 8 wk.
To generate cells expressing both Cx30 and Cx26, we transfected one cloned cell line that stably expressed Cx30 with Cx26 in pIRESneo3 (or empty vector pIRESneo3) according to the protocol described above. After selection with both 1 µg/ml of puromycin and 1 mg/ml of G418 (Invitrogen) for
3 wk, the colonies were trypsinized, and these bulk-selected cells were expanded for further studies.
Immunocytochemistry. HeLa cells were grown on coverslips for 2 days, and immunocytochemistry was performed as described (66). We screened for antibodies against Cx26 that did not cross-react with Cx30 and antibodies against Cx30 that did not cross-react with Cx26 by immunostaining cells that stably expressed Cx26 or Cx30. In this way, we found a monoclonal antibody (Zymed Laboratories 33-5800, South San Francisco, CA; diluted 1:500) and a rabbit antiserum (Zymed Laboratories 51-2800, diluted 1:1,000), both against the COOH terminus of Cx26, and a rabbit antiserum against the COOH terminus of Cx30 (Zymed Laboratories 71-2200, diluted 1:1,000) that did not cross-react. We used these antibodies in our experiments, typically the combination of the mouse anti-Cx26 and the rabbit anti-Cx30.
Immunoblot analysis and coimmunoprecipitations.
HeLa cells were harvested, the pellets were lysed, and the protein lysates were separated by SDS-PAGE, transferred over 1 h as described (66). To screen for antibodies against Cx26 that did not cross-react with Cx30 and antibodies against Cx30 that did not cross-react with Cx26, the blots were incubated with various primary antibodies against either Cx30 or Cx26 overnight at 4°C. Subsequently, the blots were incubated in peroxidase-coupled donkey antiserum against rabbit or mouse IgG (Jackson ImmunoResearch, West Grove, PA; diluted 1:10,000) for 1 h at room temperature and visualized by enhanced chemiluminescence (Amersham, Piscataway, NJ). In this way, we found that the antibodies that did not cross-react by immunostaining (described above) also did not cross-react by immunoblotting (
Fig. 2). These antibodies were used in the coimmunoprecipitation analysis.
|
|
Fluorescence resonance energy transfer assay.
For fluorescence resonance energy transfer (FRET), HeLa cells were fixed with 4% paraformaldehyde 24 h after cotransfection with equal amounts of plasmids encoding Cx-ECFP (donor) and Cx-EYFP (acceptor). To minimize the bleeding through of the ECFP emission into the EYFP emission, and vice versa, as is frequently encountered in acceptor-depletion FRET, we adopted the method of acceptor-depletion FRET with linear spectral unmixing (u-ad FRET) described by Gu and colleagues (16, 26). We acquired
stacks, each consisting of images from eight contiguous but nonoverlapping spectral channels (each 11 nm in bandwidth), extending from near the peak of the ECFP emission (474 nm) to near the peak of the EYFP emission (562 nm) with a FluoView FV1000 Olympus laser scanning confocal microscope (x60, oil immersion objective). Two argon laser lines were used: the 458-nm line of a 30-mW laser at 0.3% excitation power was used for simultaneous imaging of both ECFP and EYFP, and the 514-nm laser line was used for acceptor photobleaching because it excites only EYFP. Three
stacks were obtained, and preselected regions of interest (ROIs) were repeatedly photobleached (with the 514-nm laser) 15–20 times at 100% excitation power so that the EYFP signal was eliminated within the ROIs. After photobleaching, three more
stacks were obtained. Each individual
stack was subjected to linear unmixing using reference spectra from images of cells transfected with Cx26-ECFP, Cx30-ECFP, Cx26-EYFP, or Cx30-EYFP. The mean pixel density of ECFP and EYFP within ROIs from these "unmixed images" was exported (as an Excel file) for further analysis using the interactive software of the Olympus microscope (see supplemental Fig. S2). (Supplemental materials for this article are available online at the Am J Physiol Cell Physiol website.)
For each ROI, the mean pixel density of the three unmixed images was averaged, for both the donor (ECFP) and the acceptor (EYFP), before (ECFPpre and EYFPpre) and after (ECFPpost and EYFPpost) photobleaching. These data were used to calculate the FRET efficiency, the relative donor (D) and acceptor (A) concentration ratio (D-A ratio), and the acceptor emission (A-level) as previously described (26, 31, 67): FRET efficiency (%) = 100 x (ECFPpost – ECFPpre)/ECFPpost; D (%) = 100 x ECFPpost/(ECFPpost + EYFPpre); A (%) = 100 x EYFPpre/(ECFPpost + EYFPpre); D-A ratio = D/A; and A-level = EYFPpre.
The FRET efficiency was measured only in regions where the D-A ratio was within 0.33 and 3 to avoid calculation errors caused by low signal-to-noise ratio and FRET efficiency saturation (16, 30). The data were processed, and statistical analysis was performed with the GraphPad Prism 4 software (GraphPad Software, San Diego, CA).
Scrape loading and fluorescence recovery after photobleaching. For scrape loading, HeLa cells were grown to confluence on 60-mm plates, and the medium was changed to HBSS (without Ca2+ or Mg2+) plus one of the following fluorescence dyes: 0.1% Lucifer yellow (LY), 1 mM 5,6-carboxyfluorescein (CF), 0.1% ethidium bromide (EB), or 0.3% propidium iodide (PI), all from Sigma-Aldrich, as well as 2% neurobiotin (NB), a nonfluorescent tracer (Vector Laboratories, Burlingame, CA). A scalpel blade was used to make many parallel lines on the dish; after 5 min, cells were washed with HBSS and imaged with both fluorescence and phase-contrast optics. Cells scrape loaded with NB were fixed for 10 min in 4% paraformaldehyde, blocked (5% fish skin gelatin in PBS containing 0.1% Triton), and incubated with streptavidin-rhodamine (1:300) for 1 h at room temperature. After washing, coverslips were mounted with Vectashield and samples were photographed under a Leica fluorescence microscope with Hamamatsu digital camera C4742-95 connected to a G5 Mac computer, using the Openlab 2.2 software. Scrape loading was quantified by measuring the distance from the scrape line to the point where the fluorescence intensity dropped to 1.5 x the background intensity. For each cell line, this was measured for EB, PI, and NB by acquiring at least eight images from each of three different plates of cells. The images were processed and analyzed with NIH ImageJ software, and the mean distance was calculated with Microsoft Excel software and compared between cell lines using ANOVA (GraphPad Prism 4 software, San Diego, CA).
For fluorescence recovery after photobleaching (FRAP), cells were grown on a 35/22-mm glass bottom dish (Warner Instruments, Hamden, CT) for
40 h to 70–90% confluence, washed in HBSS, and incubated with calcein-AM (1 µM; Biotium, Haywood, CA) in Opti-MEM (Invitrogen) for 20 min, rinsed several times with HBSS, and maintained in Opti-MEM at room temperature during the experiment. With a x60 objective and the interactive software of a FluoView FV1000 Olympus laser scanning confocal microscope, we used the 488-nm line of a 30-mW Argon laser at 0.3% excitation power to detect the green fluorescence signal during the entire recording. Individual cells that were surrounded by at least four other cells were photobleached for 600 ms with a 405-nm, 25-mW diode laser at full power. The aim was to bleach maximally the selected cells, without bleaching neighboring cells.
To measure FRAP, images were acquired before bleaching and every 10 s after bleaching for 500 s, and average fluorescence intensity in the bleached cell in every image was measured as mean pixel density and exported as Excel files. One unbleached cell in the same field was also monitored for fluorescence loss throughout the experiment. In addition, individual cells that were isolated from the rest of the cells were also bleached and monitored for recovery in each dish; no recovery was observed (data not shown). Using Microsoft Excel software, the fluorescence signal intensity immediately before and immediately after photobleaching was normalized to 100% and 0%, respectively. Recovery was calculated based on the fluorescence intensity in the photobleached cell at each time point relative to the fluorescence intensity of the same cell at the same region before the bleaching and expressed as percent recovery.
For analysis of heterotypic gap junction dye coupling, one cell type was prelabeled with cell membrane dye DiI (10 µg/ml, Molecular Probes) for 20 min at 37°C. The cells were trypsinized and mixed with unlabeled cells at a ratio of 1:30, and FRAP was performed after 24–30 h as described above. The 543-nm argon laser line was used to detect the DiI fluorescence signal. To minimize phototoxicity to the cells, this image laser was turned off after the prebleaching image was obtained. Individual cells labeled with DiI (surrounded by at least 4 unlabeled cells) were selected for photobleaching. Because DiI served as a marker to identify the heterotypic cell pairs, it was never bleached during the experiment. To verify the fidelity of DiI prelabeling, one plate of cells was labeled with DiI and another plate of cells was labeled with DiO (10 µg/ml; Molecular Probes), which is a similar lipophilic dye with a different fluorescence. After coculture for 24–30 h, all cells were either DiI or DiO positive; there were no unlabeled cells and no cells were double labeled (data not shown).
Statistical analyses of the FRAP results were conducted to determine whether the slope of the curves differed from each other. A regression model with autocorrelated errors was applied to model recovery curve over time using the SAS software version 9.1, and the three parameters in the model (coefficients of quadratic term and linear term of time, as well as the constant term in the formula) between two cell lines were compared. A P value of <0.05 was considered to be significant.
Electrophysiological studies.
Electrical measurements were performed 1–3 days after cell plating. Glass coverslips with adherent cells were transferred to an experimental chamber mounted on the stage of an inverted microscope (Olympus IMT2) and superfused at room temperature (21–23°C) with bath solution containing (in mM) 140 NaCl, 5 KCl, 2 CaCl2, 1 MgCl2, 5 glucose, and 5 HEPES (pH 7.4). The patch pipettes were pulled from glass capillaries (GC150F-10; Harvard Apparatus, Edenbridge, UK) with a horizontal puller (DMZ-Universal; Zeitz-Instrumente, Augsburg, Germany) and were filled with saline containing (in mM) 120 potassium aspartate, 10 NaCl, 3 MgATP, 10 EGTA (pCa
8), and 5 HEPES (pH 7.2). When filled, the resistance of the pipettes measured 1–3 M
. Experiments were carried out on cell pairs using a double-voltage patch-clamp technique, which allowed us to control the membrane potential and transjunctional voltage (Vj) of both cells and to measure associated junctional currents (56). In experiments carried out on mixed cell pairs, the Cell Tracker green (Molecular Probes) was used to allow heterologous pairs to be identified (60).
Signal recording and analysis. Voltage and current signals were recorded with patch-clamp amplifiers (Axopatch 200), digitized with a 16-bit A/D converter (Digidata 1322A, Axon Instruments), and stored on a personal computer. Data acquisition and analysis were performed with pCLAMP 9 software. Curve fitting and statistical analysis were done with SigmaPlot and SigmaStat, respectively (Jandel Scientific). The data are presented as mean values ± SE.
| RESULTS |
|---|
|
|
|---|
As shown in Fig. 1, the cloned cell lines expressing either Cx26 (Fig. 1A) or Cx30 (Fig. 1B) had gap junction plaques on apposed cell membranes composed solely of the expected connexin. We found similar results with multiple clones of cells expressing either Cx26 or Cx30 (data not shown). Furthermore, nearly all of the cells coexpressing Cx26 and Cx30 also had gap junction plaques on apposed cell membranes composed of both connexins that were largely colocalized (Fig. 1C). Cells transfected with an "empty" expression plasmid or parental HeLa cells were not labeled with either antibody (data not shown).
Cx26 and Cx30 coimmunoprecipitation. The colocalization of Cx26 and Cx30 in the cotransfected cells suggested that they could form heteromeric hemichannels. To evaluate this possibility, we performed coimmunoprecipitation experiments. We first investigated whether the antibodies identified in the above immunostaining experiments would cross-react on immunoblots. As shown in Fig. 2A, the mouse monoclonal antibody against Cx26 and rabbit antiserum against Cx30 that we used in our immunostainings did not cross-react, nor did a rabbit antiserum against Cx26. We then used the rabbit antiserum against Cx30 to immunoprecipitate lysates from clonal cell lines that stably expressed either Cx26 alone or Cx30 alone or bulk-selected cells that expressed Cx26 and Cx30 and blotted the immunoprecipitate with a rabbit antiserum against Cx26. As shown in Fig. 2B, left, a band corresponding to Cx26 (single arrowhead) was seen in the lysate from cells expressing both Cx26 and Cx30 but not in the other two lysates. Rehybridizing the blot with a rabbit antiserum against Cx30 demonstrated that Cx30 was present in lysates from cells expressing Cx30 alone and from cells expressing both Cx26 and Cx30.
We also performed the reciprocal experiment, using a mouse monoclonal antibody against Cx26 to immunoprecipitate lysates from these cells, and blotted the immunoprecipitates with a rabbit antiserum against Cx30 (Fig. 2B, right). A band corresponding to Cx30 (double arrowheads) was seen in the lysate from cells expressing both Cx26 and Cx30 (Fig. 2B) but not in lysates from cells expressing Cx26 or Cx30 alone. Rehybridizing the blot with a rabbit antiserum against Cx26 demonstrated that it was present in lysates from cells expressing Cx26 alone and from cells expressing both Cx26 and Cx30. To show that the interaction between Cx26 and Cx30 is specific, we repeated this experiment using cells that coexpressed Cx26 and Cx30, as well as cells that coexpressed Cx26 and Cx43, as the latter pair are not thought to interact (24). As shown in supplemental Fig. S.1, right, Cx43 (triple arrowheads) was found both in the crude lysate and in the unbound fraction but not in the bound fraction of the Cx26 immunoprecipitates of cells coexpressing Cx26 and Cx43. As in Fig. 2B, Cx30 was immunoprecipitated with Cx26 (supplemental Fig. S.1, left). These results demonstrate that Cx26 and Cx30 selectively interact.
Cx26 and Cx30 interact directly, as determined by u-ad FRET.
As an independent way to determine whether Cx26 and Cx30 interact, we used FRET, an imaging technique that can demonstrate the proximity of fluorescently tagged proteins to one another. FRET is thought to only occur between molecules separated by 10 nm or less (12, 65). Because the diameter of an entire hemichannel is
7 nm (54), the individual subunits within a hemichannel should show FRET if they carry appropriate fluorophores. We adopted the method of acceptor-depletion FRET with linear spectral unmixing (16, 26) because it corrects for spectral bleeding through and provides relative concentrations of donor and acceptor fluorophores, thus allowing us to use the membrane clustering model (29, 30) to interpret our results. This model separates FRET signals arising from direct protein-protein interactions from those arising from random association. This model has been verified and used to interpret the formation of molecular complexes in the plasma membrane and ER, including connexin molecules (16, 26, 31, 46, 67). In this model, for proteins that directly interact, FRET increases as the D-A ratio decreases and is not correlated with the absolute level of the acceptor. In contrast, for proteins that interact only by random association, FRET does not correlate with the D-A ratio but increases with the absolute level of the acceptor. Proteins are considered partially clustered when FRET increases as the D-A ratio decreases and with the increase of absolute level of the acceptor.
FRET was performed on cells that were cotransfected with different combinations of Cx26-ECFP, Cx26-EYFP, Cx30-ECFP, Cx30-EYFP, and Cx43-EYFP. Cells coexpressing Cx26-ECFP/Cx26-EYFP or Cx30-ECFP/Cx30-EYFP and Cx26-ECFP/Cx43-EYFP were used as positive (16, 26) and negative (24) controls, respectively. For each group of cells that were analyzed, several ROIs showing expression of both ECFP and EYFP were selected from the cytoplasm or the cell membrane. As shown in Fig. 3, FRET efficiency increased inversely with the D-A ratio in cells coexpressing Cx30-ECFP and Cx26-EYFP. The FRET observed in ROIs from the cell membrane (including gap junction plaques) was similar to that in the cytoplasm (supplemental Fig. S.3). Because FRET efficiency also increased with the A-level, our result fits the partially clustered model, suggesting that Cx30 and Cx26 interact in molecular complexes, which are likely to be at least in part heteromeric connexons. The nature of the random association is unknown but is also found in cells expressing Cx26 or Cx30 alone. In contrast, in cells coexpressing Cx26-ECFP and Cx43-EYFP, FRET efficiency was not correlated with the D-A ratio but increased with A-level, consistent with the random association model. Our FRET data for Cx26 and Cx30 compare well with those of Di et al. (16), who did not, however, analyze cells coexpressing two connexins that do not form heteromers.
|
Functional analysis of cells expressing Cx26 and/or Cx30.
To investigate the functional properties of channels coassembled from Cx26 and Cx30, we performed scrape loading on bulk-selected cells coexpressing Cx30 and Cx26. We compared these cells to clonal cell lines stably expressing Cx26 or Cx30, parental HeLa cells, and bulk-selected cells coexpressing Cx30 and empty vector (pIRESneo3). In this assay (20), monolayers of cultured cells were cut with a scalpel blade in the presence of gap junction-permeant dyes. We used fluorescent molecules of differing size and charge: LY (457 Da, –2 charge), CF (376 Da, –2 charge), EB (394 Da, +1 charge), and PI (668 Da, +2 charge), as well as a nonfluorescent tracer (NB; 323 Da, +1), which can be visualized with fluorescently conjugated avidin. We quantified the extent of dye transfer by measuring the distance from the scrape line to the point where the fluorescence intensity dropped to 1.5 x the background fluorescence intensity. As shown in Fig. 4 and quantified in Fig. 5 and Table 1, none of these tracers diffused beyond the wounded parental cells, confirming that they are communication incompetent. Three different clonal cell lines stably expressing Cx26 robustly transferred all the tracers; examples from one cell line are shown. In contrast, three different clonal cell lines stably expressing Cx30 transferred EB, PI, and NB (all positively charged) but not LY or CF (both negatively charged); examples from one cell line are shown. Cells expressing Cx26 were more permeant to EB and PI (
2-fold) than cells expressing Cx30. Bulk-selected cells coexpressing Cx30 and Cx26 transferred all tracers, but LY and CF did not appear to diffuse as far as in cells expressing Cx26 alone. On the other hand, cells expressing both Cx26 and Cx30 spread PI and NB further than cells expressing Cx26 or Cx30 alone, whereas bulk-selected cells that express both Cx30 and the empty vector used to express Cx26-transferred tracers such as cells expressing Cx30 alone. These findings demonstrate that homotypic Cx26 and homotypic Cx30 channels have different permeability properties and suggest that the gap junctions formed by cells that coexpress both Cx26 and Cx30 have "emergent" permeation properties; that is, they are more permeable to NB. This argument assumes that all cells express about equal numbers of functioning channels, which was not simultaneously determined in these experiments, but is consistent with the electrophysiological data presented below (
Table 3). To exclude the possibility of dye passage from cell to cell through other mechanisms such as cytoplasmic bridges, we also scrape loaded cells with the gap junction-impermeant 10,000-Da tetramethylrhodamine dextran, which was confined to the scrape-loaded cells in all of the cell lines (data not shown).
|
|
|
|
|
|
15% of their prebleach signal after 500 s, which was, nevertheless, detectably greater than that in parental cells, which recovered only 4% after 500 s. Cells expressing both Cx26 and Cx30 (presumably heteromeric and heterotypic channels of Cx26 and Cx30) recovered 50% of their prebleach signal after 165 s, intermediate between that of cells expressing Cx26 alone and cells expressing Cx30 alone. To ensure that our FRAP results were not caused by the reentry of calcein-AM from the solution or by the spontaneous recovery of fluorescence, we also bleached individual cells that were not in contact with any other cells. Fluorescence did not return in bleached isolated cells (data not shown). For statistical analysis, regression model with autocorrelated errors was applied to obtain a fit for the recovery curves over time, and three parameters in the model (coefficients of quadratic term and linear term of time, as well as the constant term) between two cell lines were compared. These curves were significantly different among all of the cell lines (P < 0.0001), except for those between Cx30 and Cx30/vector, as shown in Table 2. FRAP analysis of homotypic Cx26, homotypic Cx30, and heterotypic Cx26-Cx30 coupling. Because Cx26 and Cx30 are coexpressed in the cochlea, we wished to determine whether these two connexins could form heterotypic channels that pass calcein. By modifying our FRAP assay, we developed a way to perform this analysis, which is conceptually similar to the "preloading" assay described by Abraham et al. (1). One cell type (clonal cell lines stably expressing Cx26 or Cx30) was prelabeled with DiI and cocultured with unlabeled cells at 1:30. After 24–30 h in coculture, the cells were incubated with calcein-AM, and individual DiI-labeled cells (which were in close contact with at least 4 non-DiI-labeled cells) were bleached and analyzed by FRAP as described above. To minimize phototoxicity to the cells, DiI was not bleached, and the laser used to detect the DiI signal was turned off after the prebleaching image was obtained. We analyzed between 25 and 46 individual cells in each combination of cocultured cells.
When DiI-labeled cells expressing Cx26 were cocultured with cells expressing Cx26, FRAP was robust, recovering 50% of their prebleach signal after just 35 s (Fig. 6D), as in our prior analysis (Fig. 6B). When DiI-labeled cells expressing Cx30 were cocultured with cells expressing Cx30, FRAP was very slow, recovering only 13% after 500 s (Fig. 6D), as in our prior analysis (Fig. 6B). Coculturing DiI-labeled cells expressing Cx26 with cells expressing Cx30 or, conversely, coculturing DiI-labeled cells expressing Cx30 with cells expressing Cx26 both showed an intermediate degree for FRAP (Fig. 6D), recovering 47% and 41% after 500 s, respectively. These results are summarized in Fig. 6D, which depicts the mean percent recovery plotted against time postbleaching; the vertical bars represent means ± SE. These recovery curves were significantly different statistically among the four cell pairs (P < 0.0001), as shown in Table 2.
Electrophysiological characterization of gap junction channels in cells expressing Cx26 and/or Cx30.
Gap junctional currents in pairs of HeLa cells transfected with Cx26 and/or Cx30 were analyzed by the double whole cell patch-clamp technique. Analysis of these cell pairs showed considerable electrical coupling via gap junctions. To distinguish between gap junctions and cytoplasmic bridges, the preparations were treated by exposure to CO2 (56), which abolishes intercellular currents due to gap junctions but does not affect cytoplasmic bridges. Table 3 summarizes the total junctional conductance and single-channel conductance in different cell pairs investigated. The mean macroscopic conductance between homotypic cell pairs expressing Cx26 and Cx30 was 8.4 and 12.7 nS, respectively. Division of these macroscopic coupling data by the single-channel conductance values for Cx26 (95 pS) and Cx30 (135 pS) yielded an estimate of
90 functioning channels between each type of homotypic cell pair on average.
The relationship between Vj and junctional conductance was also studied in cell pairs expressing various combinations of Cx30 and/or Cx26. The junctional currents observed in homotypic Cx30 cell pairs exhibited significant time and voltage dependence (Fig. 7A), similar to that reported for mouse Cx30 (57). In contrast, the junctional currents in Cx26 cell pairs (Fig. 7B) showed little if any Vj dependence, typical of homotypic Cx26 channels (24, 58). The voltage-dependent behavior of the macroscopic junctional currents in heterotypic Cx26-Cx30 cell pairs appeared intermediate between the behaviors of homotypic Cx26 and Cx30 channels. Some heterotypic cell pairs demonstrated moderate voltage dependence (Fig. 7C, left); other cell pairs showed stronger Vj gating when the Cx26 side was negative or the Cx30 side was positive (Fig. 7C, right). Rectification and activation of gap junction currents are features of heterotypic channels that have been shown previously (56, 60) and may reflect heterotypic channels composed from connexins with opposite gating polarities. The currents observed in pairs coexpressing Cx26/Cx30 (Fig. 7D) exhibited a complex voltage dependence ranging from significant sensitivity to Vj (Fig. 7D, top left) to virtually insensitive examples (Fig. 7D, top right), with additional intermediate and/or asymmetrical Vj dependence in other pairs (Fig. 7D, bottom). Moreover, in some cell pairs, the currents closely resembled those of homotypic Cx26 or homotypic Cx30 channels. Such behavior is expected when the two coexpressed connexins have distinct sensitivities because the junctional current profile depends on the expression level of the two connexins, i.e., variations in the protein ratio of Cx26 and Cx30 in different cell pairs and thus the corresponding ratio of homotypic, heterotypic, and heteromeric channels formed (56).
|
140 pS and then only reached a current level corresponding to 60-pS conductance, which presumably reflects a channel substate. Microscopic currents recorded from homotypic Cx26 cell pairs (Fig. 8B) showed typical single-channel events with unitary conductances of 100–110 pS induced only at much higher voltage (Vj = 90 mV) compared with Cx30. A residual state was largely absent for homotypic Cx26 channels. Such single-channel conductances and Vj gating correspond to mouse Cx26 channels reported under the same experimental conditions (58).
|
|
50–60, 80–110, and
120–150 pS. The 80- to 110-pS and 120- to 150-pS groups could correspond to homotypic Cx26 and Cx30 channels, respectively, because events with such conductances were recorded from these cell pairs (Figs. 8), but the distribution of unitary conductances of heterotypic Cx26-Cx30 channels also overlaps these two groups. The 50- to 60-pS channel group may be a novel conductance, reflecting heteromeric Cx26/Cx30 channels, but we cannot exclude the possibility that it reflects substate conductances of homotypic Cx30 or heterotypic Cx26-Cx30 channels or transitions between substates (see Fig. 8A, bottom, for comparison). All cell pairs occasionally contained some small conductance events (
25–30 pS, see Fig. 8B) that presumably correspond to endogenous HeLa cell channels (i.e., Cx45) (17, 18, 27, 60). Coexpression of two connexins could hypothetically produce 196 distinct heteromeric conductance states. Although the channel types shown may not be the only ones present in coexpressing cells, they represent examples of what was observed in multichannel and single-channel recordings and are consistent with the possibility of heteromeric channel formation.
|
| DISCUSSION |
|---|
|
|
|---|
Different gap junction channels have different permeabilities. We compared the permeability of gap junction channels composed of Cx26 or Cx30 by scrape loading, revealing that homotypic Cx26 channels were permeable to both cationic and anionic tracers, whereas homotypic Cx30 channels were permeable to cationic but not anionic tracers. The charge selectivity of Cx30 channels appeared to be independent of mass, as LY and EB have similar molecular weights, but opposite charges. Our results are consistent with previous studies in which tracers were injected into single cells (5, 19, 37, 39, 49), but we performed a more quantitative analysis. Even for cationic tracers (EB and PI and possibly NB), our data indicate that homotypic Cx26 channels are more permeant than homotypic Cx30 channels.
With scrape loading, we found that cells coexpressing Cx26 and Cx30 showed an intermediate degree of permeability to anionic dyes (LY, CF) than did cells expressing Cx26. These findings confirm the work of Sun et al. (49), who found that AlexaFluor 488 (an anionic dye) spreads between cells coexpressing Cx26-EGFP and Cx30-EGFP but not between cells expressing Cx30-EGFP alone but contradict a previous report that HeLa cells coexpressing Cx26 and Cx30 did not transfer injected anionic dyes Cascade blue or LY (39). Technical issues may account for their failure to find transfer of these dyes, including the fact that cells were injected and that rat Cx26 and mouse Cx30 were used. In addition, our observation that NB and PI diffused further in cells that express both Cx26 and Cx30 than in cells that express either one alone is consistent with quantitative differences in the diffusion of Ca2+ reported by Sun et al. (49). Thus channels from cells that express both Cx26 and Cx30 appear to have an "emergent property" that is distinct from that of their individual components, but the nature of the heterotypic channel is not clear.
Furthermore, we extended the investigation of the permeability of these cells with FRAP (10, 61), demonstrating that both the rate and the amount of calcein transferred between cells coexpressing Cx26 and Cx30 were intermediate to those in cells expressing Cx26 or Cx30 alone. Without the sensitivity of FRAP, we would not have detected that Cx30 homotypic channels were slightly permeable to calcein. For analysis of monolayers of cells, FRAP is highly reproducible, thereby allowing an unprecedented, quantitative analysis of dye diffusion through gap junctions.
Cx26 and Cx30 form functional heterotypic channels. We used a novel adaptation of FRAP to show that the transfer of calcein (an anionic dye) through Cx26-Cx30 heterotypic channels was intermediate between homotypic channels composed of Cx26 (which transferred calcein robustly) and Cx30 (which transferred calcein minimally). Thus one connexin does not completely determine the permeability of a heterotypic pair; these differences were not noted in a prior study that used NB only (37). Prior studies (injecting one cell of a cell pair) indicate that other combinations of heterotypic channels [e.g., Cx40-Cx43 (55), Cx26-Cx32 (11)] have intermediate levels of dye transfer compared with their homotypic counterparts (15).
Voltage gating of Cx26 and Cx30 mixed channels. The voltage-gating properties of homotypic Cx26 and Cx30 channels that we and others have documented in vitro are not directly comparable to the data obtained from isolated pairs of cochlear supporting cells, which show asymmetrical voltage gating (53, 70). Thus simple homotypic Cx26 or Cx30 channels cannot explain the voltage gating seen in cochlear supporting cells, in which Cx26 and Cx30 have been proposed to form heteromeric and/or heterotypic gap junction channels with variable stoichiometry (70). The voltage-dependent behavior of the macroscopic junctional currents that we recorded here between both Cx26-Cx30 heterotypic and Cx26/Cx30 heteromeric cell pairs closely resembled the complex voltage dependence recorded in primary cochlear supporting cells, indicating that Cx26 and Cx30 form mixed channels in supporting cells. The single-channel properties of cells expressing both Cx26 and Cx30 are more complex. Despite altered junctional permeability and biochemical evidence that support heteromeric channel formation, we cannot clearly distinguish heteromeric channels from heterotypic ones based on the unitary conductance data alone.
Implications for disease. It has been proposed that mutations in GJB2/Cx26, GJB6/Cx30, KCNQ1, KCNQ4, and KCNE1 cause hearing loss by disrupting K+ recycling in the cochlea (32, 45, 47). The variable overlapping expression of Cx26 and Cx30 in the cochlear supporting cells may result in the asymmetrical voltage gating (70) that has been hypothesized to directionally funnel K+ away from the sensory cells after acoustic stimulation (53, 69). If heteromeric and/or heterotypic channels are required for K+ recycling, then the loss of either Cx26 or Cx30 would disrupt K+ homeostasis because neither one can compensate for the loss of the other in this regard.
Other data suggest that the role of gap junctional communication in the cochlea may not be limited to K+ recycling. For example, targeted ablation of Cx26 in the cochlear epithelium causes hearing impairment and progressive death of hair cells but does not alter the expression of Cx30 or affect the endocochlear potential before the onset of cell death (13). Similarly, the pattern of Cx26 expression in the cochlea is not affected in Gjb6/Cx30-null mice, which also develop hearing loss (50). Despite the above arguments, it is problematic that Cx26 and Cx30 do not compensate for each other in these animal models because both homotypic Cx26 and homotypic Cx30 channels are permeable to K+ (37, 57), and Cx26 and Cx30 have broadly overlapping (but not identical) distributions and a similar profile of developmental expression (2, 23, 28, 49, 71). Finally, some Cx26 mutants that are associated with hearing loss have no abnormal electrophysiological characteristics, including K+ permeability, but have impaired permeability to inositol 1,4,5-trisphosphate passage (6, 68).
The selectivity for size and charge, as well as the temporal and kinetic differences in the permeability to charged molecules, of homotypic Cx26-Cx26, homotypic Cx30-Cx30, and heterotypic (and likely heteromeric) Cx26-Cx30 channels demonstrated by this and other studies may be relevant to this issue. The discrepancies between the results found in cells that express both Cx26 and Cx30 as opposed to only one of these connexins form the basis for this inference. Thus cells expressing both Cx26 and Cx30 have faster intercellular Ca2+ signaling (49) and are more permeable to NB (this study). This has been better demonstrated for Cx26-Cx32 heteromeric channels, which are selectively permeable to cAMP, cGMP, and inositol 1,4,5-trisphosphate unlike the corresponding homotypic channels (36).
Given these considerations, it is quite surprising that overexpression of the mouse Gjb2/Cx26 gene (as a transgene) can rescue hearing loss in Gjb6/Cx30-null mice (3). The Gjb2/Cx26 transgene restores the level of Cx26 protein, which is reduced in Gjb6/Cx30-null mice, and prevents the degeneration of the cochlea. According to these findings, heteromeric Cx26-Cx30 channels do not appear to be required for normal hearing; the amount of Cx26 protein seems to be key. Given this result, it would be informative to replace the Gjb6/Cx30 gene with the Gjb2/Cx26 gene, as comparable gene replacements in the lens (62) and heart (42) did not completely "rescue" the phenotype of the missing connexin.
| GRANTS |
|---|
|
|
|---|
| ACKNOWLEDGMENTS |
|---|
| FOOTNOTES |
|---|
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
| REFERENCES |
|---|
|
|
|---|
2. Ahmad S, Chen SP, Sun JJ, Lin X. Connexins 26 and 30 are co-assembled to form gap junctions in the cochlea of mice. Biochem Biophys Res Commun 307: 362–368, 2003.[CrossRef][Web of Science][Medline]
3. Ahmad S, Tang W, Chang Q, Qu Y, Hibshman J, Li Y, Sohl G, Willecke K, Chen P, Lin X. Restoration of connexin26 protein level in the cochlea completely rescues hearing in a mouse model of human connexin30-linked deafness. Proc Natl Acad Sci USA 104: 1337–1341, 2007.
4. Barrio LC, Capel J, Jarillo JA, Castro C, Revilla A. Species-specific voltage-gating properties of connexin-45 junctions expressed in Xenopus oocytes. Biophys J 73: 757–769, 1997.[Web of Science][Medline]
5. Beltramello M, Bicego M, Piazza V, Ciubotaru CD, Mammano F, DAndrea P. Permeability and gating properties of human connexins 26 and 30 expressed in HeLa cells. Biochem Biophys Res Commun 305: 1024–1033, 2003.[CrossRef][Web of Science][Medline]
6. Beltramello M, Piazza V, Bukauskas FF, Pozzan T, Mammano F. Impaired permeability to Ins(1,4,5)P3 in a mutant connexin underlies recessive hereditary deafness. Nat Cell Biol 7: 63–69, 2005.[CrossRef][Web of Science][Medline]
7. Brink PR, Cronin K, Banach K, Peterson E, Westphale EM, Seul KH, Ramanan SV, Beyer EC. Evidence for heteromeric gap junction channels formed from rat connexin43 and human connexin37. Am J Physiol Cell Physiol 273: C1386–C1396, 1997.
8. Bruzzone R, White TW, Paul DL. Connections with connexins: the molecular basis of direct intercellular signaling. Eur J Biochem 238: 1–27, 1996.[Web of Science][Medline]
9. Bukauskas FF, Bukauskiene A, Bennett MV, Verselis VK. Gating properties of gap junction channels assembled from connexin43 and connexin43 fused with green fluorescent protein. Biophys J 81: 137–152, 2001.[Web of Science][Medline]
10. Cameron SJ, Malik S, Akaike M, Lerner-Marmarosh N, Yan C, Lee JD, Abe J, Yang J. Regulation of epidermal growth factor-induced connexin 43 gap junction communication by big mitogen-activated protein kinase1/ERK5 but not ERK1/2 kinase activation. J Biol Chem 278: 18682–18688, 2003.
11. Cao FL, Eckert R, Elfgang C, Nitsche JM, Snyder SA, Hulser DF, Willecke K, Nicholson BJ. A quantitative analysis of connexin-specific permeability differences of gap junctions expressed in HeLa transfectants and Xenopus oocytes. J Cell Sci 111: 31–43, 1998.[Abstract]
12. Clegg RM. Fluorescence resonance energy transfer. Curr Opin Biotechnol 6: 103–110, 1995.[CrossRef][Medline]
13. Cohen-Salmon M, Ott T, Michel V, Hardelin JP, Perfettini I, Eybalin M, Wu T, Marcus DC, Wangemann P, Willecke K, Petit C. Targeted ablation of connexin26 in the inner ear epithelial gap junction network causes hearing impairment and cell death. Curr Biol 12: 1106–1111, 2002.[CrossRef][Web of Science][Medline]
14. Common JEA, Becker D, Di WL, Leight IM, O'Toole EA, Kelsell DP. Functional studies of human skin disease- and deafness-associated connexin 30 mutations. Biochem Biophys Res Commun 298: 651–656, 2002.[CrossRef][Web of Science][Medline]
15. Cottrell GT, Burt JM. Functional consequences of heterogeneous gap junction channel formation and its influence in health and disease. Biochim Biophys Acta 1711: 126–141, 2005.[Medline]
16. Di WL, Gu Y, Common JEA, Aasen T, OToole EA, Kelsell DP, Zicha D. Connexin interaction patterns in keratinocytes revealed morphologically and by FRET analysis. J Cell Sci 118: 1505–1514, 2005.
17. Eckert R. Gap-junctional single-channel permeability for fluorescent tracers in mammalian cell cultures. Biophys J 91: 565–579, 2006.[CrossRef][Web of Science][Medline]
18. Eckert R, Dunina-Barkovskaya A, Hulser DF. Biophysical characterization of gap-junction channels in HeLa cells. Pflügers Arch 424: 335–342, 1993.[CrossRef][Web of Science][Medline]
19. Elfgang C, Eckert R, Lichternberg-Frate H, Butterweck A, Traub O, Klein RA, Hulser DF, Willecke K. Specific permeability and selective formation of gap junction channels in connexin-transfected HeLa cells. J Cell Biol 129: 805–817, 1995.
20. El-Fouly M, Trosko J, Chang C. Scrape-loading and dye transfer. A rapid and simple technique to study gap junctional intercellular communication. Exp Cell Res 168: 422–430, 1987.[CrossRef][Web of Science][Medline]
21. Fawcett DW. The Cell. Philadelphia, PA: Saunders, 1981.
22. Forge A, Becker D, Casalotti S, Edwards J, Marziano N, Nevill G. Gap junctions in the inner ear: comparison of distribution patterns in different vertebrates and assessment of connexin composition in mammals. J Comp Neurol 467: 207–229, 2003.[CrossRef][Web of Science][Medline]
23. Forge A, Becker D, Casalotti S, Edwards J, Marziano N, Nickel R. Connexins and gap junctions in the inner ear. Audiol Neurootol 7: 141–145, 2002.[CrossRef][Medline]
24. Gemel J, Valiunas V, Brink PR, Beyer EC. Connexin43 and connexin26 form gap junctions, but not heteromeric channels in co-expressing cells. J Cell Sci 117: 2469–2480, 2004.
25. Gonzalez D, Gomez-Hernandez JM, Barrio LC. Species specificity of mammalian connexin-26 to form open voltage-gated hemichannels. FASEB J 20: 2329–2338, 2006.
26. Gu Y, Di W, Kelsell D, Zicha D. Quantitative fluorescence resonance energy transfer (FRET) measurement with acceptor photobleaching and spectral unmixing. J Microsc 215: 162–173, 2004.[Web of Science][Medline]
27. Hulser DF, Rehkopf B, Traub O. Dispersed and aggregated gap junction channels identified by immunogold labeling of freeze-fractured membranes. Exp Cell Res 233: 240–251, 1997.[CrossRef][Web of Science][Medline]
28. Jagger DJ, Forge A. Compartmentalized and signal-selective gap junctional coupling in the hearing cochlea. J Neurosci 26: 1260–1268, 2006.
29. Kenworthy A. Peering inside lipid rafts and caveolae. Trends Biochem Sci 27: 435–437, 2002.[CrossRef][Web of Science][Medline]
30. Kenworthy AK, Edidin M. Distribution of a glycosylphosphatidylinositol-anchored protein at the apical surface of MDCK cells examined at a resolution of <100 A using imaging fluorescence resonance energy transfer. J Cell Biol 142: 69–84, 1998.
31. Kenworthy AK, Petranova N, Edidin M. High-resolution FRET microscopy of cholera toxin B-subunit and GPI-anchored proteins in cell plasma membranes. Mol Biol Cell 11: 1645–1655, 2000.
32. Kikuchi T, Adams JC, Miyabe Y, So E, Kobayashi T. Potassium ion recycling pathway via gap junction systems in the mammalian cochlea and its interruption in hereditary nonsyndromic deafness. Med Electron Microsc 33: 51–56, 2000.[CrossRef][Medline]
33. Kikuchi T, Kimura RS, Paul DL, Adams JC. Gap junctions in the rat cochlea: immunohistochemical and ultrastructural analysis. Anat Embryol (Berl) 191: 101–118, 1995.[Medline]
34. Kumar NM, Gilula NB. The gap junction communication channel. Cell 84: 381–389, 1996.[CrossRef][Web of Science][Medline]
35. Lautermann J, tenCate WJF, Altenhoff P, Grummer R, Traub O, Frank HG, Jahnke K, Winterhager E. Expression of the gap-junction connexins 26 and 30 in the rat cochlea. Cell Tissue Res 294: 415–420, 1998.[CrossRef][Web of Science][Medline]
36. Locke D, Stein T, Davies C, Morris J, Harris AL, Evans WH, Monaghan P, Gusterson B. Altered permeability and modulatory character of connexin channels during mammary gland development. Exp Cell Res 298: 643–660, 2004.[CrossRef][Web of Science][Medline]
37. Manthey D, Banach K, Desplantez T, Lee CG, Kozak CA, Traub O, Weingart R, Willecke K. Intracellular domains of mouse connexin26 and-30 affect diffusional and electrical properties of gap junction channels. J Membr Biol 181: 137–148, 2001.[Web of Science][Medline]
38. Martin PEM, Coleman SL, Casalotti SO, Forge A, Evans WH. Properties of connexin26 gap junctional proteins derived from mutations associated with nonsyndromal hereditary deafness. Hum Mol Genet 8: 2369–2376, 1999.
39. Marziano NK, Casalotti SO, Portelli AE, Becker DL, Forge A. Mutations in the gene for connexin 26 (GJB2) that cause hearing loss have a dominant negative effect on connexin 30. Hum Mol Genet 12: 805–812, 2003.
40. Nagy JI, Ochalski PAY, Li J, Hertzberg EL. Evidence for the co-localization of another connexin with connexin-43 at astrocytic gap junctions in rat brain. Neuroscience 78: 533–548, 1997.[CrossRef][Web of Science][Medline]
41. Ormo M, Cubitt AB, Kallio K, Gross LA, Tsien RY, Remington SJ. Crystal structure of the Aequorea victoria green fluorescent protein. Science 273: 1392–1395, 1996.[Abstract]
42. Plum A, Hallas G, Magin T, Dombrowski F, Hagendorff A, Schumacher B, Wolpert C, Kim JS, Lamers WH, Evert M, Meda P, Traub O, Willecke K. Unique and shared functions of different connexins in mice. Curr Biol 10: 1083–1091, 2000.[CrossRef][Web of Science][Medline]
43. Rabionet R, Gasparini P, Estivill X. Molecular genetics of hearing impairment due to mutations in gap junction genes encoding beta connexins. Hum Mutat 16: 190–202, 2000.[CrossRef][Web of Science][Medline]
44. Richard G. Connexin gene pathology. Clin Exp Dermatol 28: 397–409, 2003.[CrossRef][Web of Science][Medline]
45. Santos-Sacchi J. The effects of cytoplasmic acidification upon electrical coupling in the organ of Corti. Hear Res 19: 207–215, 1985.[CrossRef][Web of Science][Medline]
46. Silvius JR. Fluorescence energy transfer reveals microdomain formation at physiological temperatures in lipid mixtures modeling the outer leaflet of the plasma membrane. Biophys J 85: 1034–1045, 2003.[Web of Science][Medline]
47. Steel KP. Perspectives, biomedicine: the benefits of recycling. Science 285: 1363–1364, 1999.
48. Sullivan R, Lo CW. Expression of a connexin 43/beta-galactosidase fusion protein inhibits gap junctional communication in NIH3T3 cells. J Cell Biol 130: 419–429, 1995.
49. Sun JJ, Ahmad S, Chen SP, Tang WX, Zhang YP, Chen P, Lin X. Cochlear gap junctions coassembled from Cx26 and 30 show faster intercellular Ca2+ signaling than homomeric counterparts. Am J Physiol Cell Physiol 288: C613–C623, 2005.
50. Teubner B, Michel V, Pesch J, Lautermann J, Cohen Salmon M, Sohl G, Jahnke K, Winterhager E, Herberhold C, Hardelin JP, Petit C, Willecke K. Connexin30 (Gjb6)-deficiency causes severe hearing impairment and lack of endocochlear potential. Hum Mol Genet 12: 13–21, 2003.
51. Thomas T, Aasen T, Hodgins M, Laird DW. Transport and function of cx26 mutants involved in skin and deafness disorders. Cell Commun Adhes 10: 353–358, 2003.[CrossRef][Web of Science][Medline]
52. Thomas T, Jordan K, Simek J, Shao Q, Jedeszko C, Walton P, Laird DW. Mechanisms of Cx43 and Cx26 transport to the plasma membrane and gap junction regeneration. J Cell Sci 118: 4451–4462, 2005.
53. Todt I, Ngezahayo A, Ernst A, Kolb HA. Hydrogen peroxide inhibits gap junctional coupling and modulates intracellular free calcium in cochlear Hensen cells. J Membr Biol 181: 107–114, 2001.[Web of Science][Medline]
54. Unger VM, Kumar NM, Gilula NB, Yeager M. Projection structure of a gap junction membrane channels at 7 A resolution. Nat Struct Biol 4: 1997.
55. Valiunas V, Beyer EC, Brink PR. Cardiac gap junction channels show quantitative differences in selectivity. Circ Res 91: 104–111, 2002.
56. Valiunas V, Gemel J, Brink PR, Beyer EC. Gap junction channels formed by coexpressed connexin40 and connexin43. Am J Physiol Heart Circ Physiol 281: H1675–H1689, 2001.
57. Valiunas V, Manthey D, Vogel R, Willecke K, Weingart R. Biophysical properties of mouse connexin30 gap junction channels studied in transfected human HeLa cells. J Physiol 519: 631–644, 1999.
58. Valiunas V, Niessen H, Willecke K, Weingart R. Electrophysiological properties of gap junction channels in hepatocytes isolated from connexin32-deficient and wild-type mice. Pflügers Arch 437: 846–856, 1999.[CrossRef][Web of Science][Medline]
59. Valiunas V, Polosina YY, Miller H, Potapova IA, Valiuniene L, Doronin S, Mathias RT, Robinson RB, Rosen MR, Cohen IS, Brink PR. Connexin-specific cell-to-cell transfer of short interfering RNA by gap junctions. J Physiol 568: 459–468, 2005.
60. Valiunas V, Weingart R, Brink PR. Formation of heterotypic gap junction channels by connexins 40 and 43. Circ Res 86: E42–E49, 2000.[Web of Science][Medline]
61. Wade MH, Trosko JE, Schindler M. A fluorescence photobleaching assay of gap junction-mediated communication between human cells.. Science 232: 525–528, 1986.
62. White TW. Nonredundant gap junction functions. News Physiol Sci 18: 95–99, 2003.
63. White TW, Bruzzone R. Multiple connexin proteins in single intercellular channels: connexin compatibility and functional consequences. J Bioenerg Biomembr 28: 339–350, 1996.[CrossRef][Web of Science][Medline]
64. Willecke K, Eiberger J, Degen J, Eckardt D, Romualdi A, Guldenagel M, Deutsch U, Söhl G. Structural and functional diversity of connexin genes in the mouse and human genome. Biol Chem 383: 725–737, 2002.[CrossRef][Web of Science][Medline]
65. Wu P, Brand L. Resonance energy transfer: methods and applications. Anal Biochem 218: 1–13, 1994.[CrossRef][Web of Science][Medline]
66. Yum SW, Kleopa KA, Shumas S, Scherer SS. Diverse trafficking abnormalities for connexin32 mutants causing CMTX. Neurobiol Dis 11: 43–52, 2002.[CrossRef][Web of Science][Medline]
67. Zacharias DA, Violin JD, Newton AC, Tsien RY. Partitioning of lipid-modified monomeric GFPs into membrane microdomains of live cells. Science 296: 913–916, 2002.
68. Zhang Y, Tang W, Ahmad S, Sipp JA, Chen P, Lin X. Gap junction-mediated intercellular biochemical coupling in cochlear supporting cells is required for normal cochlear functions. Proc Natl Acad Sci USA 102: 15201–15206, 2005.
69. Zhao HB, Kikuchi T, Ngezahayo A, White TW. Gap junctions and cochlear homeostasis. J Membr Biol 209: 177–186, 2006.[CrossRef][Web of Science][Medline]
70. Zhao HB, Santos-Sacchi J. Voltage gating of gap junctions in cochlear supporting cells: evidence for nonhomotypic channels. J Membr Biol 175: 17–24, 2000.[CrossRef][Web of Science][Medline]
71. Zhao HB, Yu N. Distinct and gradient distributions of Connexin26 and Connexin30 in the cochlear sensory epithelium of guinea pigs. J Comp Neurol 499: 506–518, 2006.[CrossRef][Web of Science][Medline]
This article has been cited by other articles:
![]() |
I. Sargiannidou, N. Vavlitou, S. Aristodemou, A. Hadjisavvas, K. Kyriacou, S. S. Scherer, and K. A. Kleopa Connexin32 Mutations Cause Loss of Function in Schwann Cells and Oligodendrocytes Leading to PNS and CNS Myelination Defects J. Neurosci., April 15, 2009; 29(15): 4736 - 4749. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Mese, V. Valiunas, P. R. Brink, and T. W. White Connexin26 deafness associated mutations show altered permeability to large cationic molecules Am J Physiol Cell Physiol, October 1, 2008; 295(4): C966 - C974. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Kanaporis, G. Mese, L. Valiuniene, T. W. White, P. R. Brink, and V. Valiunas Gap Junction Channels Exhibit Connexin-specific Permeability to Cyclic Nucleotides J. Gen. Physiol., March 31, 2008; 131(4): 293 - 305. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |